Bohnacker, T., Prota, A. E., Beaufils, F., Burke, J. E., Melone, A., Inglis, A. J., . . . Wymann, M. P. (2017). Deconvolution of Buparlisib's mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic intervention. Nat Commun.
Styl ChicagoBohnacker, Thomas, et al. "Deconvolution of Buparlisib's Mechanism of Action Defines Specific PI3K and Tubulin Inhibitors for Therapeutic Intervention." Nat Commun 2017.
Citace podle MLABohnacker, Thomas, et al. "Deconvolution of Buparlisib's Mechanism of Action Defines Specific PI3K and Tubulin Inhibitors for Therapeutic Intervention." Nat Commun 2017.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..